RT Journal Article
SR Electronic
T1 Disseminated hydatid disease of lungs
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA2529
DO 10.1183/13993003.congress-2016.PA2529
VO 48
IS suppl 60
A1 Bahrom Amonov
A1 Shuhrat Khudaybergenov
A1 Georgy Pakhomov
A1 Rustem Hayaliev
A1 Davlathon Maksumov
YR 2016
UL http://erj.ersjournals.com/content/48/suppl_60/PA2529.abstract
AB Hydatid disease - a serious parasitic disease of humans, which is endemic to the Central Asian republics, including Uzbekistan. The number of operations performed per year now exceeds 1.5 thousand. On the data of the literature the relapse of hydatid disease after surgical treatment does not tend to decrease and changes from 4% up to 48%.In the department of surgery of lungs and mediastinum from 1975 to 2015yy there were 3054 patients with hydatid disease of lungs. From 2945 operated patients concerning the various forms of hydatid disease of lungs relapse of disease from 1 to 7 years we observed in 193 (6,31%) patients. Men - 119 (61,6%), women - 74 (38,4%). The age of the patients varied from 9 to 74 years. From 155 patients (80,3%) undergone operations, not operated 38 (19,7%) - the reason was disseminated process, wide distribution of hydatid cysts. 140 (72,5%) patients were performed organsaving operation, 15 (7,8%) patients underwent resections.In the postoperative period albendazole was administered in a doze 10-12 mg/kg/day, quantity of courses depended on the form of a defeat. Using preventive chemotherapy realistically reduces the risk of the development of the relapse of hydatid disease, hereunder, rescuing patient from the repeated operations and possible complications. The following picture shows relapsed multiplural hydatid disease of lungs.